Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

Treatment of sleep disturbance in Alzheimer's dementia.

Salami O, Lyketsos C, Rao V.

Int J Geriatr Psychiatry. 2011 Aug;26(8):771-82. doi: 10.1002/gps.2609. Epub 2010 Sep 24. Review.

PMID:
20872779
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Non-pharmacologic management of sleep disturbance in Alzheimer's disease.

David R, Zeitzer J, Friedman L, Noda A, O'Hara R, Robert P, Yesavage JA.

J Nutr Health Aging. 2010 Mar;14(3):203-6. Review.

PMID:
20191254
[PubMed - indexed for MEDLINE]
3.

Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.

Vitiello MV, Borson S.

CNS Drugs. 2001;15(10):777-96. Review.

PMID:
11602004
[PubMed - indexed for MEDLINE]
4.

Cholinesterase inhibitors for Alzheimer's disease.

Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593. Review.

PMID:
16437532
[PubMed - indexed for MEDLINE]
5.

The neurobiology of neuropsychiatric syndromes in dementia.

Meeks TW, Ropacki SA, Jeste DV.

Curr Opin Psychiatry. 2006 Nov;19(6):581-6. Review.

PMID:
17012935
[PubMed - indexed for MEDLINE]
6.

[Sleep rhythm disturbances in Alzheimer's disease].

Onen F, Onen SH.

Rev Med Interne. 2003 Mar;24(3):165-71. Review. French.

PMID:
12657438
[PubMed - indexed for MEDLINE]
7.

WITHDRAWN: Support for carers of people with Alzheimer's type dementia.

Thompson C, Spilsbury K.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000454. Review.

PMID:
17636637
[PubMed - indexed for MEDLINE]
8.

Support for carers of people with Alzheimer's type dementia.

Thompson C, Briggs M.

Cochrane Database Syst Rev. 2000;(2):CD000454. Review. Update in: Cochrane Database Syst Rev. 1998;(3):CD000454.

PMID:
10796545
[PubMed - indexed for MEDLINE]
9.

Sleep disorders in Alzheimer's disease and other dementias.

Bliwise DL.

Clin Cornerstone. 2004;6 Suppl 1A:S16-28. Review.

PMID:
15259536
[PubMed - indexed for MEDLINE]
10.

Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.

Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N.

Health Technol Assess. 2001;5(1):1-137. Review.

PMID:
11262420
[PubMed - indexed for MEDLINE]
Free Article
11.

Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.

Fioravanti M, Flicker L.

Cochrane Database Syst Rev. 2001;(4):CD003159. Review.

PMID:
11687175
[PubMed - indexed for MEDLINE]
12.

The nature and management of sleep/wake disturbance in Alzheimer's dementia.

Reynolds CF 3rd, Hoch CC, Stack J, Campbell D.

Psychopharmacol Bull. 1988;24(1):43-8. Review. No abstract available.

PMID:
3290948
[PubMed - indexed for MEDLINE]
13.

Metal protein attenuating compounds for the treatment of Alzheimer's dementia.

Sampson EL, Jenagaratnam L, McShane R.

Cochrane Database Syst Rev. 2012 May 16;5:CD005380. doi: 10.1002/14651858.CD005380.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;2:CD005380.

PMID:
22592705
[PubMed - indexed for MEDLINE]
14.

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

Loveman E, Green C, Kirby J, Takeda A, Picot J, Payne E, Clegg A.

Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. Review.

PMID:
16409879
[PubMed - indexed for MEDLINE]
Free Article
15.

Evidence-based pharmacotherapy of Alzheimer's disease.

Evans JG, Wilcock G, Birks J.

Int J Neuropsychopharmacol. 2004 Sep;7(3):351-69. Epub 2004 Jul 1. Review.

PMID:
15228642
[PubMed - indexed for MEDLINE]
16.

Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.

Burns A, O'Brien J; BAP Dementia Consensus group, Auriacombe S, Ballard C, Broich K, Bullock R, Feldman H, Ford G, Knapp M, McCaddon A, Iliffe S, Jacova C, Jones R, Lennon S, McKeith I, Orgogozo JM, Purandare N, Richardson M, Ritchie C, Thomas A, Warner J, Wilcock G, Wilkinson D; British Association for Psychopharmacology.

J Psychopharmacol. 2006 Nov;20(6):732-55. Review.

PMID:
17060346
[PubMed - indexed for MEDLINE]
17.

WITHDRAWN: Tacrine for Alzheimer's disease.

Qizilbash N, Birks J, Lopez Arrieta J, Lewington S, Szeto S.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000202. Review.

PMID:
17636619
[PubMed - indexed for MEDLINE]
18.

[Sleep disturbances in Alzheimer's disease and other dementias].

Vecchierini MF.

Psychol Neuropsychiatr Vieil. 2010 Mar;8(1):15-23. doi: 10.1684/pnv.2010.0203. Review. French.

PMID:
20215095
[PubMed - indexed for MEDLINE]
19.

[Sleep disorders and dementia].

Hess CW.

Praxis (Bern 1994). 1997 Aug 27;86(35):1343-9. Review. German.

PMID:
9381026
[PubMed - indexed for MEDLINE]
20.

Tacrine for Alzheimer's disease.

Qizilbash N, Birks J, López-Arrieta J, Lewington S, Szeto S.

Cochrane Database Syst Rev. 2000;(2):CD000202. Review. Update in: Cochrane Database Syst Rev. 2000;(3):CD000202.

PMID:
10796507
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk